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Purpose: Opioids may affect changes in the corrected QT interval (QTc) during an-
esthetic induction. This study examine whether a single bolus of remifentanil would 
prolong QTc after laryngeal mask airway (LMA) insertion during sevoflurane induc-
tion. Materials and Methods: Forty women of American Society of Anesthesiolo-
gists physical status 1 (ASA PS1) undergoing gynecological surgery were studied. 
All patients were induced using three vital capacity inhalation inductions with 5% 
sevoflurane. Two minutes after induction, the inspiratory concentration of sevoflu-
rane was reduced to 2%. Using double-blinded randomization, patients were allocat-
ed into one of two groups, receiving either saline (placebo group, n = 20) or 0.25 
µg.kg-1 remifentanil (remifentanil group, n = 20) over a period of thirty seconds. Six-
ty seconds later, LMA insertion was performed. Recordings were taken with a 12-
lead electrocardiogram at baseline, 2 min after induction and 1 and 3 min after LMA 
insertion. QTc was calculated by Bazett’s formula. The mean arterial pressure 
(MAP) and heart rate (HR) were also measured at each time point. Results: The 
QTc interval was significantly prolonged in the placebo group as compared to the 
remifentanil group at 1 min after LMA insertion (467.8 ± 16.5 vs. 442.7 ± 21.3 ms, p 
< 0.001). However, there was no significant difference in QTc at 3 min after LMA 
insertion between the two groups. MAP and HR were significantly higher in the pla-
cebo group (p < 0.001). Conclusion: A single bolus of remifentanil is safe method to 
attenuate prolonged QTc associated with insertion of LMA. 
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INTRODUCTION
The QT interval, measured from the beginning of the QRS complex to the end of 
the T wave on a standard ECG, represents the duration of the action potential of 
heart ventricles. 
The corrected QT interval (QTc) varies with the heart rate (HR). Faster HR (the 
shorter the RR interval) results in a shorter QTc, and vice versa. Therefore, the QTc 
is usually corrected for HR using Bazett’s formula (QTc = QT/√RR, with all inter-
vals in seconds) which remains the gold standard for clinical use despite some limi-
tations at particularly fast or slow HRs. Sevoflurane, desflurane, thiopental and pro-Eun Sung Kim and Hae Wone Chang
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Committee, women of American Society of Anesthesiolo-
gists physical status 1 (ASA PS1), aged between 25 and 49 
years, and scheduled for elective gynecological day case 
surgery were included in the study and upon receipt of their 
written informed consent. All of the surgeries were per-
formed between 8:00 a.m. and 11:00 a.m. to minimize the 
influence of the circadian variation in cardiac autonomic 
nervous activity. Patients were excluded from the study if 
any of following criteria were present: 1) use of any QT-
prolonging drug for 14 days; 2) idiopathic or acquired pro-
longed QT interval in preoperative ECG (QTc > 440 ms); 
3) existence of arrhythmia, bundle branch block pattern or 
preexcitation; 4) structural heart disease; 5) endocrine dis-
order; 6) malignancy; 7) electrolyte abnormality; 8) obesity 
(body mass index > 30); 9) pregnancy; 10) contraindica-
tions for the use of LMA.
The patients were randomly placed into one of the two 
groups based on a computer-generated sequence of num-
bers. Fig. 1 provides a summary of the study protocol. 
No anti-cholinergic drugs were given because they can 
cause increases in the QT interval. Vital signs were mea-
sured when the patients arrived in the operating room, which 
included ECG monitoring, non-invasive arterial pressure 
and pulse oximetry. After 10 minutes of stabilization, digi-
talized 12-lead ECGs were recorded on a Philips Pagewrit-
er (Pagewriter Trim III, Philips, Netherlands) that simulta-
neously acquired the 12-lead readings for 10 seconds at a 
sampling rate of 100 Hz with a resolution of 5 µV. 
The anesthetic circuits were pre-filled with 5% sevoflu-
rane for 3 minutes. All patients received pre-oxygenation 
for 3 minutes with 6 L min-1 oxygen from another oxygen 
source. Then patients exhaled residual volume and took 
three maximum vital capacity breaths of a gas mixture of 
sevoflurane through a mask connected to the pre-filled an-
esthetic circuit, as they had previously been instructed. 
Thereafter ventilation was assisted with positive pressure 
pofol have been shown to prolong the QTc intreval.1,2 In 
healthy patients, this prolongation seems to have no harmful 
effects. However, those who are at risk, including those suf-
fering from hypokalemia, those with a genetic predisposition 
or those who have taken two or more drugs that lengthen 
QTc, may be predisposed to fatal ventricular arrhythmia.3   
Fentanyl, the mu(μ)-opioid agonist, is the most frequent-
ly used opioid in anesthesia. Review of literature has shown 
that fentanyl interferes with K+ currents in human cardiac 
cells transfected with the human ether-a-go-go-related gene 
(HERG) potassium channel gene,4 and that fentanyl may 
shorten the QTc in congenital long QT syndrome as well as 
in healthy patients.5,6 
Remifentanil, the most recently released opioid agonist, 
is widely used in anesthesia because of its desirable phar-
macokinetic property, specifically in the field of day case 
anesthesia. Remifentanil induces a dose-dependent decrease 
in HR, arterial blood pressure and cardiac output.7 However, 
there are few reports describing the effect of remifentanil on 
QTc changes during anesthesia.8,9 
One microgram per kilogram of remifentanil was shown 
to reduce the prolongation of QTc following laryngoscopy 
and intubation in one study.8 However, the efficacy of remi-
fentanil in attenuating QTc response to laryngeal mask air-
way (LMA) insertion is unknown.  
Therefore, the aim of this study was to investigate the ef-
fects of a single bolus of remifentanil administered prior to 
LMA insertion on QTc interval during sevoflurane induc-
tion in healthy, unpremedicated women undergoing minor 
gynecological day case surgery in a placebo-controlled, 
randomized, double-blinded study environment. 
MATERIALS AND METHODS
After obtaining approval from the Hospital Research Ethics 
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Fig. 1. Study protocol. Open bar = 5% sevoflurane, Filled bars = 2% sevoflurane; Saline or remifentanil was given after 2 min of inhalation 
of sevoflurane. Effects of Remifentanil on Corrected QT Interval
Yonsei Med J   http://www.eymj.org   Volume 52   Number 2   March 2011 335
20 ms using a t-test. Intergroup comparisons were per-
formed using Student’s t-tests or Chi-square tests for inde-
pendent data. Differences within groups were evaluated us-
ing repeated measures ANOVA with post-analysis of the 
Dunnett test. A p value of < 0.05 was considered to be sta-
tistically significant. 
RESULTS
Forty-six patients were recruited to participate in this study. 
In the remifentanil group, two patients were excluded due 
to the need for more than one attempt at LMA insertion, 
and one was excluded due to the use of rescue drugs before 
obtaining an ECG curve. In the placebo group, two patients 
were excluded due to prolonged LMA insertion time, and 
one was excluded because of the poor quality of the ECG 
curve obtained. Therefore, both groups consisted of twenty 
patients at the end of the study. 
The patients in both groups were comparable in age, 
weight, height, pre-induction HR, pre-induction MAP and 
pre-induction QTc (Table 1). 
In the placebo group, significant increases in QTc values 
were observed one minute after LMA insertion as com-
pared to the values obtained before anesthesia and to the 
corresponding time points in the remifentanil group (467.8 
± 16.5 vs. 442.7 ± 21.3 ms, p < 0.001)(Fig. 2). Three min-
utes after LMA insertion, the QTc values remained pro-
longed as compared to the corresponding baseline values in 
both groups. The numbers of patients with QTc prolonga-
tion over 450 ms in each study group are compared as 
shown in Table 2. In the remifentanil group, there were sig-
nificantly fewer patients with prolonged QTc of over 450 
ms. In the placebo group, QTc values > 480 ms were noted 
in four patients. In remifentanil group, QTc values > 480 ms 
were noted in two patients. There were no observations of 
QTc values > 500 ms in either group.
ventilation to keep the end tidal CO2 between 30-35 mmHg. 
After loss of eyelash reflex, 0.05 mg.kg-1 of vecuronium 
was given to facilitate the insertion of LMA. After 2 minutes 
of induction, the remifentanil group received 0.25 µg.kg-1 
of remifentanil in 10 mL of saline over a 30 second period, 
and the placebo group received the same volume of saline. 
The remifentanil dose was chosen based on doses from our 
preliminary studies. The inspiratory concentration of sevo-
flurane was set at 2%. 1 minute after administration of the 
study drug an anesthesiologist who was blinded to the study 
inserted the LMA. If insertion was not completed within 40 
seconds, the patient was excluded from further study. The 
QTc, HR and mean arterial pressures (MAP) were noted at 
the following stages: pre-induction, 2 minutes after sevoflu-
rane induction, and 1 and 3 minutes after LMA insertion. 
Hypotension (Systolic arterial pressure < 80 mmHg for > 
60 s) was treated with IV administration of 3 mg of ephed-
rine. Bradycardia (HR < 45 beat min-1 for > 60 s) was treat-
ed with 0.5 mg dose of atropine after QTc data collection. 
The case was excluded from the study if rescue drug had to 
be given before completion of the study period. Once the 
study was completed, the surgery was allowed to proceed 
and anesthesia was maintained with sevoflurane. 
QT intervals were estimated manually from the onset of 
the QRS complex to the end of the T wave (defined as the 
junction of the isoelectric line and the tangent of the maxi-
mal downward limb of the T wave) by a cardiologist who 
did not aware of study group assignment. QTc values were 
calculated according to Bazett’s formula.  Percentage of pa-
tients with prolonged QTc over 450, 480 and 500 ms in 
both study groups were compared.10
The data were analyzed by GraphPad Prizm version 5.0 
for Windows (San Diego, CA, USA). The variables were 
expressed as mean ± SD. A sample size of 14 patients per 
group was necessary based on calculations with 80% pow-
er (p = 0.05, β = 0.2) to detect a mean QTc interval differ-
ence of 22 ms between groups and a standard deviation of 
Table 1. Demographic Data of the Patients 
Placebo group (n = 20) Remifentanil group (n = 20)
Age (yrs) 36.8 ± 8.0 38.20 ± 6.1
Weight (kg) 54.4 ± 6.7 56.3 ± 7.5
Height (cm) 158.2 ± 4.3 160.4 ± 5.5
Pre-induction QTc (ms) 433.1 ± 13.5    425 ± 14.7
Pre-induction HR (bpm) 74.6 ± 9.3   78.1 ± 14.2
Pre-induction MAP (mmHg) 95.5 ± 9.2   93.7 ± 12.7
QTc, corrected QT interval; HR, heart rate; MAP, mean arterial pressures.
Values are represented as mean ± SD.Eun Sung Kim and Hae Wone Chang
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QT syndrome (LQTS) who may present for incidental mi-
nor surgery or may require anesthesia for insertion of a 
pacemaker or implantable automatic defibrillator.
A few studies have investigated the effect of this relatively 
new opioid agonist, remifentanil, on QTc intervals. Kweon, 
et al.8 reported that 1 μg.kg-1 of remifentanil is effective in 
preventing intubation- related QTc prolongation in healthy 
patients. Continuous infusion of 0.1 μg.kg-1min-1 of remifent-
anil has been shown to prevent fatal arrhythmia in patients 
with a long QT syndrome.9 In an animal study, remifentanil 
depressed sinus node and AV nodal function, but it did not af-
fect QTc at doses typically used in clinical settings.12 
In this study, we tried to evaluate the efficacy of low dose 
remifentanil in attenuating QTc intervals during LMA in-
sertion with sevoflurane induction. 
The remifentanil dose required to facilitate LMA inser-
tion has been estimated to be 0.25 to 0.3 μg.kg-1 in associa-
tion with propofol, without the need for neuromuscular 
blocking agents.13,14 
Suzuki, et al.15 reported that taking multiple deep breaths 
of 5% sevoflurane with 67% N2O was comparable to 2 
mgkg-1 of propofol for insertion of LMA. Our pilot studies 
suggested that the lowest dose of remifentanil prevents un-
wanted bradycardia. 
HR in the placebo group was significantly higher at one 
minute after insertion of LMA than before administration 
of anesthesia (p < 0.05)(Fig. 3). In the remifentanil group, 
HR was significantly lower at 1 and 3 minutes after LMA 
insertion than before anesthesia administration (p < 0.05).   
MAP decreased significantly 2 minutes after sevoflurane 
anesthesia in both groups, compared with the values before 
anesthesia (p < 0.05)(Fig. 4). In the remifentanil group, 
MAP was significantly lower one minute after LMA inser-
tion than before anesthesia administration, whereas MAP 
had increased significantly in the placebo group.
In both groups, MAP values returned to the pre-anesthe-
sia values within 3 minutes after LMA insertion.  
DISCUSSION
The main purpose of this study was to evaluate the addition 
of a small dose of remifentanil before LMA insertion dur-
ing inhalation induction with 5% sevoflurane in terms of its 
effects on QTc intervals and hemodynamic effects. Because 
LMA insertion is far less stimulating than direct laryngos-
copy and endotracheal intubation,11 LMA may be a more 
desirable airway instrument for patients with known long 
Table 2. Number of Patients with QTc Prolongation above 450 ms (Correction with Bazett’s Formula)
Number of patients
with QTc > 450 ms in
placebo group (n = 20)
Number of patients 
with QTc > 450 ms in
remifentanil group (n = 20)
p value
QTc 1 min after LMA insertion  15 4 0.0005
QTc 3 min after LMA insertion    6 4 0.4562
QTc, corrected QT interval; LMA, laryngeal masic airway.
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absence of laryngeal muscle stimulation. Sevoflurane and 
remifentanil may show synergy in their antinociceptive ac-
tion.20
The predominant and usual effect of opioids on the HR is 
induction of bradycardia through stimulation of the central 
vagal nucleus. Vagal-cardiac activation with remifentanil 
may attenuate the effects of sympathetic stimulation during 
LMA insertion. 
Diverse types of potassium channel exist in myocardial 
cell membrane. The rate of repolarization of action poten-
tial are mostly controlled slowly activating (iKs) and rapid-
ly activating (iKr) delayed rectifier channels during phase 2 
and 3 of the electrical cardiac cycle. Inhalation anesthetic 
agents prolong the QTc through blocking the iKr channel. 
Effects of opioids on potassium channels was not clearly 
known. Katchman, et al.4 reported fentanyl could block car-
diac human ether-go-go related gene currents at a very high 
dose. This was consistent with the finding that during in-
duction of anesthesia in patients undergoing coronary artery 
bypass graft surgery, the QT interval increased significantly 
after injection of fentanyl.21 Though chemically related to the 
fentanyl family of short-acting phenylpiperidine derivatives, 
remifentanil is structurally unique because of its ester link-
age. We were not aware of previous studies describing the ef-
fects of remifentanil on K+ currents. 
This study has some limitations. Considering that muscle 
rigidity or inadequate relaxation may affect measurements 
of QTc, we used small dose of vecuronium. However, pre-
vious works have suggested that vecuronium has no effect 
on QTc and cardiac conduction.22
QT interval is influenced predominantly by heart rate. 
Thus, a rate-corrected QT (QTc) interval should be calcu-
lated. Bazett’s formula is the most popular in clinical prac-
tices. This formula may exaggerate drug-induced QT pro-
longation.
Generally, QT is considered to be prolonged when the 
QTc interval is greater than 440 ms in men and 460 ms in 
women, although arrhythmias are most often associated 
with values of 500 ms or more.23
The other limitations of this study are that it was per-
formed only on women and on patients without a known car-
diac disorder. Women have longer QT intervals and are more 
prone to drug-induced QT prolongation. The changes we 
found may less extensive in men. Also, it would be better to 
do later studies on patients with repolarization disorders. 
In conclusion, remifentanil reduced the prolongation of 
corrected QT interval induced by LMA insertion in patients 
In this study, we used three vital capacity breaths with the 
priming circuit technique as the inhalation induction method 
because it provided faster induction time as compared to the 
conventional stepwise increase in the dose of sevoflurane.16 A 
rapid method may be more practical in a busy day surgery 
unit setting because it requires only a few minutes to estab-
lish adequate anesthetic depth for airway instrumentation.
There are reports in the literature analyzing various mea-
sures for preventing increases in QTc following tracheal in-
tubation. Lidocaine, esmolol, fentanyl, alfentanil and remi-
fentanil have been studied in this capacity.6,8,17,18 However, 
there have been few studies reporting QTc interval change 
following LMA insertion. A remifentanil bolus has peak ef-
fect of 1-1.5 min and action duration of 3-4 min.19 We hy-
pothesized that remifentanil by bolus injection may be use-
ful for controlling transient cardiovascular stimulation and 
QTc change. 
Prevention of prolonged QTc with remifentanil adminis-
tration could be related to various mechanisms of the drug’s 
action. 
Tracheal intubation itself prolongs the QTc interval by 
activating the sympathetic nervous system. A supraglottic 
tissue irritation following direct laryngoscopy is reason for 
hemodynamic change after tracheal intubation. Therefore, 
we anticipated that avoiding stimulation of laryngeal tissue 
with the LMA may cause less of an increase in the QTc inter-
vals. However, in our study, 75% of patients in the placebo 
group, and 20% of patients in the remifentanil group, showed 
prolongation of QTc to over 450 ms during the study period. 
Inadequate pharyngeal analgesia may have a role in in-
creasing sympathoadrenal response and QTc changes in the 
Fig. 4. The change in mean arterial pressure (MAP) (mean ± SD) at differ-
ent time points under sevoflurane anesthesia. +1 and +3 min refer to time 
after insertion of laryngeal mask airway. *p < 0.001 when compared with 
placebo groups at each time point. †p < 0.05 when compared to MAP val-
ues before anesthesia.
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10. International Conference on Harmonisation of Technical Require-
ments for Registration of Pharmaceuticals for Human Use: E14: 
The clinical evaluation of QT/QTc interval prolongation and pro-
arrhytmhic potential for nonantiarrhythmic drugs (http://www.ich.
org).
11. Fujii Y, Tanaka H, Toyooka H. Circulatory responses to laryngeal 
mask airway insertion or tracheal intubation in normotensive and 
hypertensive patients. Can J Anaesth 1995;42:32-6. 
12. Zaballos M, Jimeno C, Almendral J, Atienza F, Patiño D, Valdes E, 
et al. Cardiac electrophysiological effects of remifentanil: study in 
a closed-chest porcine model. Br J Anaesth 2009;103:191-8.
13. Lee MP, Kua JS, Chiu WK. The use of remifentanil to facilitate 
the insertion of the laryngeal mask airway. Anesth Analg 2001; 
93:359-62. 
14. Grewal K, Samsoon G. Facilitation of laryngeal mask airway inser-
tion: effects of remifentanil administered before induction with tar-
get-controlled propofol infusion. Anaesthesia 2001;56:897-901.
15. Suzuki KS, Oohata M, Mori N. Multiple-deep-breath inhalation 
induction with 5% sevoflurane and 67% nitrous oxide: compari-
son with intravenous injection of propofol. J Anesth 2002;16:97-
101.
16. Epstein RH, Stein AL, Marr AT, Lessin JB. High concentration 
versus incremental induction of anesthesia with sevoflurane in 
children: a comparison of induction times, vital signs, and compli-
cations. J Clin Anesth 1998;10:41-5.
17. Korpinen R, Saarnivaara L, Siren K. QT interval of the ECG, 
heart rate and arterial pressure during anaesthetic induction: com-
parative effects of alfentanil and esmolol. Acta Anaesthesiol Scand 
1995;39:809-13.
18. Sivalingam P, Kandasamy R, Madhavan G, Dhakshinamoorthi P. 
Conditions for laryngeal mask insertion. A comparison of propofol 
versus sevoflurane with or without alfentanil. Anaesthesia 
1999;54:271-6. 
19. Hall AP, Thompson JP, Leslie NA, Fox AJ, Kumar N, Rowbotham 
DJ. Comparison of different doses of remifentanil on the cardio-
vascular response to laryngoscopy and tracheal intubation. Br J 
Anaesth 2000;84:100-2.
20. Ma D, Sapsed-Byrne SM, Chakrabarti MK, Whitwam JG. Syner-
gistic antinociceptive interaction between sevoflurane and intra-
thecal fentanyl in dogs. Br J Anaesth 1998;80:800-6.
21. Lischke V, Wilke HJ, Probst S, Behne M, Kessler P. Prolongation 
of the QT-interval during induction of anesthesia in patients with 
coronary artery disease. Acta Anaesthesiol Scand 1994;38:144-8.
22. Weber G, Stark G, Stark U. Direct cardiac electrophysiologic ef-
fects of sufentanil and vecuronium in isolated guinea-pig hearts. 
Acta Anaesthesiol Scand 1995;39:1071-4.
23. Moss AJ. Measurement of the QT interval and the risk associated 
with QTC interval prolongation: a review. Am J Cardiol 1993; 
72:23B-5. 
undergoing minor gynecological study during inhalation in-
duction with sevoflurane. A low bolus dose of remifentanil 
and LMA may be acceptable for patients with proarrythmo-
genesis. 
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